Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page adds sections for How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment header, while removing the previous Intervention / Treatment label. It also updates the recruitment status to 'No longer looking for participants' and changes the footer revision to v3.6.0.SummaryDifference0.5%

- Check18 days agoChange DetectedRevision: v3.5.5 was added and previously v3.5.4 was removed, indicating a new site build/version. This change updates the site metadata without altering the study details.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision history shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating a small metadata update to the entry. This does not reflect substantive changes to study details or content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page’s software/display footer revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now lists Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to study details or page layout.SummaryDifference0.1%

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.